Pharma Reviews: Govt sets up council to boost local manufacturing, export of medical devices

In a major fillip to medical devices industry, the Indian government has decided to set up a National Medical Devices Promotion Council under the ...
Read more: Govt sets up council to boost local manufacturing, export of medical devices

Pharma Reviews: Indian pharma market growth likely to be in double digits in 2019

Healthcare sector may see further consolidation in 2019 with tightening of regulatory environment set to make it difficult for small players to stay afloat ...
Read more: Indian pharma market growth likely to be in double digits in 2019

Pharma Reviews: Healthcare sector may see further consolidation in 2019

"We expect a good recovery for the pharma sector in the domestic market. The Indian pharma market growth is likely to be in double digits and we will ...
Read more: Healthcare sector may see further consolidation in 2019

Pharma Reviews: Top 19 for 2019: Stocks that could give double-digit returns in a year

We expect Ashok Leyland to benefit as the Indian MHCV industry is .... of the biggest integrated pharma companies in India with a strong presence in ...
Read more: Top 19 for 2019: Stocks that could give double-digit returns in a year

Pharma Reviews: Now Indian stents represent more than 50% of the market : Gurmeet Singh Chugh

The creation of every new drug diluting stent is almost equivalent to creating a new pharma molecule. Now within Indian companies, we face two ...
Read more: Now Indian stents represent more than 50% of the market : Gurmeet Singh Chugh

Pharma Reviews: From Zinetac to Calpol, top 10 drugs drive India revenue for big firms

A few thousand brand launches happen in the Rs 1.2-trillion domestic pharmaceuticals industry every year. Almost all major drugmakers market a few ...
Read more: From Zinetac to Calpol, top 10 drugs drive India revenue for big firms

Product Recall Alerts: FDA issues alert, voluntary recall on cardiovascular medication

Recalls of prescription drugs used to treat cardiovascular conditions continue with the Food and Drug Administration issuing a Dec. 20 alert on certain ...
Read more: FDA issues alert, voluntary recall on cardiovascular medication

Pharma Reviews: Outlook 2019: Pharma looks medically fit for double-digit growth after years of suffering

Indian pharma companies have been going through a tough phase for the past couple of years due to significant competitive intensity and pricing ...
Read more: Outlook 2019: Pharma looks medically fit for double-digit growth after years of suffering

Pharma Reviews: Indian Pharma, Sugar and Agri Industry should invest in Sudan, says Indian Ambassador to Sudan

Hyderabad, Dec 28 (UNI) Mr Ravindra P Jaiswal, IFS, Ambassador of India to Sudan invited investors from the Agri, Food Processing, Sugar ...
Read more: Indian Pharma, Sugar and Agri Industry should invest in Sudan, says Indian Ambassador to Sudan

Pharma Reviews: 'NMDPC' was long-standing need of Indian medical devices industry: CII

National Medical Devices Promotion Council, set up under the Department of Industrial Promotion and Policy, will help promote growth of the sector ...
Read more: 'NMDPC' was long-standing need of Indian medical devices industry: CII

Pharma Reviews: National Medical Devices Promotion Council to fuel growth of domestic industry: CII

The industry chamber said that it was a long-standing need of the medical devices industry in India. "Time has come for the medical technology sector ...
Read more: National Medical Devices Promotion Council to fuel growth of domestic industry: CII

Pharma Reviews: Rising shipments to US help Indian pharma exports rebound in H1FY19

Indian pharmaceutical exports grew 12.2 percent to $10.8 billion year-on-year (YoY) in the first half of FY19, riding on generic drug launches, easing of ...
Read more: Rising shipments to US help Indian pharma exports rebound in H1FY19

Pharma Reviews: ICRA assigns stable outlook for Indian Pharma companies

ICRA has given a stable outlook on the Indian pharmaceutical industry. The headwinds from pricing pressure in large regulated markets, especially ...
Read more: ICRA assigns stable outlook for Indian Pharma companies

Pharma Reviews: Sun Pharma: Global Is Local

Sun was one of first Indian pharma companies to invest in these areas. “We are meticulously nurturing the specialty business and have built a portfolio ...
Read more: Sun Pharma: Global Is Local

Pharma Reviews: Closing bell: Sensex up 157 points, Nifty fails to hold 10800 as banking stocks drag

Mumbai: Indian shares extended gains for a second straight session on .... The company on Wednesday said its arm DUSA Pharmaceuticals has ...
Read more: Closing bell: Sensex up 157 points, Nifty fails to hold 10800 as banking stocks drag

Pharma Reviews: Motilal Oswal's 10 stocks to bet on in 2019

Indian hospitality industry is set to enter an upcycle, led by favourable ... the biggest integrated pharma companies in India with strong presence in US, ...
Read more: Motilal Oswal's 10 stocks to bet on in 2019

Pharma Reviews: Share market update: Pharma shares slip; Sun Pharma down nearly 3%

Shares of Sun Pharmaceutical Industries (down 2.69 per cent), Piramal ... Shares of YES Bank, Indian Oil Corp, Bank of Baroda, Tata Motors, SAIL, ...
Read more: Share market update: Pharma shares slip; Sun Pharma down nearly 3%

Pharma Reviews: Holistic quality enhancement is the need of the hour: 70th Indian Pharmaceutical Congress

Whereas the Indian diagnostics market was a $ 9.6 million industry, just under 20% of Indians have ever given their blood for testing while Tier III & IV ...
Read more: Holistic quality enhancement is the need of the hour: 70th Indian Pharmaceutical Congress

Pharma Reviews: Biocon Says Won't Play The Bloodbath Game In Indian Market For Now

Biocon Ltd.—India's second-best performing pharmaceutical stock this year—will continue to focus on Europe and the U.S. in 2019. That's according ...
Read more: Biocon Says Won't Play The Bloodbath Game In Indian Market For Now

Pharma Reviews: Make India global capital for generic medicines: Naidu

Vice President M. Venkaiah Naidu on Friday called up on the pharmaceutical industry to work towards making India an international capital of generic ...
Read more: Make India global capital for generic medicines: Naidu

Pharma Reviews: India wants China to allow import of drugs cleared by US, Europe

Almost 1,500 Indian products have obtained clearances from the food and pharmaceutical regulators of the US, EU and Japan, but only 535 are ...
Read more: India wants China to allow import of drugs cleared by US, Europe

Pharma Reviews: Cost of HIV/AIDS treatment down globally due to Indian firms: VP Naidu

Noida (UP): Due to the ability of the Indian pharma companies to produce drugs at economical rates, the cost of HIV/AIDS treatment has gone down to ...
Read more: Cost of HIV/AIDS treatment down globally due to Indian firms: VP Naidu

Pharma Reviews: 70th Indian Pharmaceutical Congress commences in NCR

With the theme Pharma Vision 2030 aimed at establishing India as the global industry leader, the 70th edition of the Indian Pharmaceutical Congress ...
Read more: 70th Indian Pharmaceutical Congress commences in NCR

Pharma Reviews: Pharma sector: Earnings downgrade is yet to bottom out

A large chunk of incremental investments by Indian pharmaceutical companies have been in complex and specialty. The sector's R&D spends have ...
Read more: Pharma sector: Earnings downgrade is yet to bottom out

US FDA News: FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk

The FDA authorized use of a new test that measures nutrients in breast milk providing healthcare professionals with tool to aid in the nutritional management of newborns.
Read more: FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk

Pharma Reviews: Cost of HIV/AIDS treatment down globally due to Indian firms: Venkaiah Naidu

Due to the ability of the Indian pharma companies to produce drugs at economical rates, the cost of HIV/AIDS treatment has gone down to $400 per ...
Read more: Cost of HIV/AIDS treatment down globally due to Indian firms: Venkaiah Naidu

Pharma Reviews: Cost of HIV/AIDS treatment down globally due to Indian firms: VP Naidu

Due to the ability of the Indian pharma companies to produce drugs at economical rates, the cost of HIV/AIDS treatment has gone down to USD 400 ...
Read more: Cost of HIV/AIDS treatment down globally due to Indian firms: VP Naidu

Pharma Reviews: Business Top 5: TCS, UPL, Torrrent Pharma, Sun Pharma, stock market wrap

Business Top 5: TCS, UPL, Torrrent Pharma, Sun Pharma, stock market wrap ... He also stated that India as a Pharma market will continue to grow in ...
Read more: Business Top 5: TCS, UPL, Torrrent Pharma, Sun Pharma, stock market wrap

Pharma Reviews: VP Naidu addresses 70th Indian Pharmaceutical Congress at Amity University

The Vice President of India, Shri M. Venkaiah Naidu has called upon the pharmaceutical industry to work towards making India an International ...
Read more: VP Naidu addresses 70th Indian Pharmaceutical Congress at Amity University

Pharma Reviews: Indian Pharma industry projected to grow 55 Million USD by 2020

Noida – Addressing the 70th Indian Pharmaceutical Congress at Amity University, Noida , Vice President Naidu said that India becoming the largest ...
Read more: Indian Pharma industry projected to grow 55 Million USD by 2020

US FDA News: FDA approves new treatment for adult patients with rare, life-threatening blood disease

The FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.
Read more: FDA approves new treatment for adult patients with rare, life-threatening blood disease

US FDA News: FDA approves first treatment for rare blood disease

The FDA approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.
Read more: FDA approves first treatment for rare blood disease

Pharma Reviews: Naidu says make India an international capital of generic medicines

Addressing the 70th Indian Pharmaceutical Congress at Amity University in Noida, Mr Naidu said that apart from being the world leader in generic ...
Read more: Naidu says make India an international capital of generic medicines

Pharma Reviews: Make India the international capital for Generic Medicines, says Vice President

Vice President of India, Shri M. Venkaiah Naidu has called up on the pharmaceutical industry to work towards making India an International Capital of ...
Read more: Make India the international capital for Generic Medicines, says Vice President

Pharma Reviews: Over 150 volunteers from IPCA initiate Swachh Bharat Drive within Amity Campus

Cleanliness drive was organized on the run-up to the 70th Indian Pharmaceutical Congress (IPC) which will be held from December 21 to 23 at Amity ...
Read more: Over 150 volunteers from IPCA initiate Swachh Bharat Drive within Amity Campus

Pharma Reviews: India provides access to life-saving medicines at affordable prices: Vice President

Addressing Indian Pharmaceutical Congress in Noida on Friday, Mr Naidu said, rural health programmes, lifesaving drugs and preventive vaccines ...
Read more: India provides access to life-saving medicines at affordable prices: Vice President

Pharma Reviews: 5 lessons Dalal Street taught us in 2018 & 5 themes to bet on for 2019

Indian pharma companies, which are focusing on building complex and specialty products pipeline, would be able to sustain better profitability ...
Read more: 5 lessons Dalal Street taught us in 2018 & 5 themes to bet on for 2019

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Pharma Reviews: Industry to discuss various critical issues during pharma event

The pharmaceutical industry would deliberate on various issues related to generic drugs and medical devices at 70th edition of Indian Pharmaceutical ...
Read more: Industry to discuss various critical issues during pharma event

Pharma Reviews: All You Need To Know Going Into Trade On Dec. 20

Coal India seeks to buy coking coal mines in Australia and Canada. ... This film is mainly used in dairy industry for flavored milk, pharma industry and ...
Read more: All You Need To Know Going Into Trade On Dec. 20

US FDA News: Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients

FDA review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the main artery of the body, called the aorta. These tears, called aortic dissections, or ruptures of an aortic aneurysm can lead to dangerous bleeding or even death. They can occur with fluoroquinolones for systemic use given by mouth or through an injection.
Read more: Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales

The FDA provides update on Essure postmarket review study as company prepares to halt sales of the device on December 31.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales

US FDA News: FDA warns about safety risks of teething necklaces, bracelets to relieve teething pain or to provide sensory stimulation

FDA alerted parents, caregivers and health care providers to the safety risks that jewelry used for relieving teething pain pose for children.
Read more: FDA warns about safety risks of teething necklaces, bracelets to relieve teething pain or to provide sensory stimulation

US FDA News: FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

FDA sends warning letter to Genetech, Inc. and letters to other companies to reiterate the FDA’s compliance and enforcement policy regarding stem cells.
Read more: FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

Pharma Reviews: Stocks To Watch: Coal India, GSK, Religare Enterprises, Tata Consultancy Services

Uflex launched three packaging foil solutions for pharma companies. Executive Director Amitava Ray said that the 'fast tear strip' foil will prove to be a ...
Read more: Stocks To Watch: Coal India, GSK, Religare Enterprises, Tata Consultancy Services

Pharma Reviews: Pharma's tough year concludes; hopes up for a better 2019

The calendar year, just concluding, has arguably been a tough year for most of the Indian pharmaceutical companies. Most of them, especially the ...
Read more: Pharma's tough year concludes; hopes up for a better 2019

Pharma Reviews: Quality can't be ensured without stringent regulations

Even as Indian generics share the lion's share of the global market, closer home, they have missed the paramount objective of 'alleviating diseases by ...
Read more: Quality can't be ensured without stringent regulations

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety

FDA announces steps being taken on two medical device programs: finalizing guidance on the Breakthrough Device Program and announcing plans for a new Safer Technologies Program (STeP).
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship

FDA’s 2017 report of sales/distribution data for antimicrobial drugs for food animals showed a continued decline in sales, a reflection of improved antimicrobial stewardship
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship

US FDA News: Michigan-based food manufacturer agrees to stop operations after repeated food safety violations

Saranac Brand Foods, Inc. specialized in a variety of 35 different ready-to-eat foods, including prepared salads, dips, and sauces.
Read more: Michigan-based food manufacturer agrees to stop operations after repeated food safety violations

Pharma Reviews: China emerging as big opportunity for Indian pharma: Pharmexcil

Hyderabad: With China easing regulations in the pharma sector, many Indian players are now showing interest in foraying into that market, Pharmexcil ...
Read more: China emerging as big opportunity for Indian pharma: Pharmexcil

Pharma Reviews: The way forward for Healthcare sector in India

Indian pharma companies have proven time and again that they are good at manufacturing low cost generic drugs that can benefit the patient, and ...
Read more: The way forward for Healthcare sector in India

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Frank Yiannas on new findings and updated consumer recommendations related to the romaine lettuce E. coli O157:H7 outbreak investigation

Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Frank Yiannas on new findings and updated consumer recommendations related to the romaine lettuce E. coli O157:H7 outbreak investigation
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner Frank Yiannas on new findings and updated consumer recommendations related to the romaine lettuce E. coli O157:H7 outbreak investigation

Pharma Reviews: Closing bell: Sensex up 150 points, Nifty ends at 10791, Yes Bank shares fall 6%

Mumbai: Indian benchmark indices BSE Sensex and NSE's Nifty 50 continued .... complaint against Dilip Shanghvi-led Sun Pharmaceutical Industries.
Read more: Closing bell: Sensex up 150 points, Nifty ends at 10791, Yes Bank shares fall 6%

Pharma Reviews: The 12th Edition of CPhI P-MEC India Expo Witnessed a Spectacular Opening in its Debut in Delhi ...

The reputed CPhI Global Pharma Index ranks India no. 1 in terms of pharma market growth potential, and within the top 3 countries on the parameter ...
Read more: The 12th Edition of CPhI P-MEC India Expo Witnessed a Spectacular Opening in its Debut in Delhi ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development

FDA announces withdrawal of the proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development

Pharma Reviews: The 12th Edition of CPhI & P-MEC India Expo Witnessed a Spectacular Opening in its Debut in ...

1 in terms of pharma market growth potential, and within the top 3 countries on the parameter of competitiveness. India has also taken giant strides to ...
Read more: The 12th Edition of CPhI & P-MEC India Expo Witnessed a Spectacular Opening in its Debut in ...

Pharma Reviews: The Tiger Finds Its Way Into The Dragon Cave: Aurobindo Pharma's Subsidiary To Form Joint ...

Indian pharmaceutical major, Aurobindo Pharma's subsidiary, Helix Healthcare BV, will form a Joint Venture (JV) with the Chinese pharma company, ...
Read more: The Tiger Finds Its Way Into The Dragon Cave: Aurobindo Pharma's Subsidiary To Form Joint ...

Pharma Reviews: Indian pharmaceutical meet: Impact of e-pharma on agenda

New Delhi, Dec 11 (IANS) The upcoming “Indian Pharmaceutical Congress 2018” would discuss various aspects of the industry including the impact ...
Read more: Indian pharmaceutical meet: Impact of e-pharma on agenda

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice

FDA releases guidance with recommendations for drug manufacturers regarding good manufacturing practices and data integrity
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice

Pharma Reviews: Industry welcomes TRS victory

This could be followed up by setting up mega industrial townships on ... not have much impact on pharma exports as Indian pharmaceutical industry is ...
Read more: Industry welcomes TRS victory

US FDA News: FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.
Read more: FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

Pharma Reviews: Indian pharmaceutical meet: Impact of e-pharma on agenda

The upcoming "Indian Pharmaceutical Congress 2018" would discuss various aspects of the industry including the impact of e-pharmacy players on ...
Read more: Indian pharmaceutical meet: Impact of e-pharma on agenda

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework

FDA announces new actions advancing the agency’s biosimilars policy framework
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework

Product Recall Alerts: Recall Alert: 3 Brands of Infants' Ibuprofen Recalled for Higher Concentrations of Medicine

Three brands of Infants' Ibuprofen Concentrated Oral Suspension are being voluntarily recalled by Tris Pharma, Inc. for potentially higher ...
Read more: Recall Alert: 3 Brands of Infants' Ibuprofen Recalled for Higher Concentrations of Medicine

US FDA News: Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

FDA provides updates to postmarketing studies that agency ordered three manufacturers of duodenoscopes to conduct to assess bacterial contamination of devices.
Read more: Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data

Pharma Reviews: Acute therapy segments pull down domestic pharma sales growth to 6% in Nov

While Indian companies grew 6.2 per cent for the month, multinational firms grew slightly faster at 6.8 per cent for the same period. Amongst the top 60 ...
Read more: Acute therapy segments pull down domestic pharma sales growth to 6% in Nov

Pharma Reviews: India pharma market slows due to lower offtake of anti-infective, respiratory drugs

The Indian pharmaceutical market (IPM) grew 6.3 percent in November, much slower than the previous month, due to lower offtake of anti-infective ...
Read more: India pharma market slows due to lower offtake of anti-infective, respiratory drugs

Pharma Reviews: Over 8000 to participate in 70th Indian Pharma Congress

Indian Pharmaceutical Congress (IPC) is held every year in the country under the aegis of Indian Pharmaceutical Congress Association (IPCA) which ...
Read more: Over 8000 to participate in 70th Indian Pharma Congress

US FDA News: FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs

FDA clears a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder
Read more: FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs

FDA releases guidance with recommendations for protecting patients from the risk of contaminated or substandard compounded products produced by outsourcing facilities.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs

Pharma Reviews: 70th Indian Pharmaceutical Congress to begin on Dec 21

The 70th Indian Pharmaceutical Congress (IPC) is all set to be inaugurated by Vice President of India, Venkaiah Naidu on December 21. Around ...
Read more: 70th Indian Pharmaceutical Congress to begin on Dec 21

Pharma Reviews: Pharma torch bearers congregate to select industry's best in class in Mumbai

Members of the jury overseeing the presentation by nominated pharma firms at the second and final jury selection round at the India Pharma Awards.
Read more: Pharma torch bearers congregate to select industry's best in class in Mumbai

Pharma Reviews: The Murky Affairs Of Sun Pharma

Among the large corporates in India, Sun Pharmaceuticals Ltd., India's biggest pharma company, stood out as a relatively clean organisation, whose ...
Read more: The Murky Affairs Of Sun Pharma

Product Recall Alerts: Childrens' Pain Reliever Recalled Due to Potentially Higher Potency Level

Tris Pharma announced a voluntary nationwide recall of 3 lots of Infants' Ibuprofen Concentrated Oral Suspension, 50mg/1.25mL as the products may ...
Read more: Childrens' Pain Reliever Recalled Due to Potentially Higher Potency Level

Product Recall Alerts: Parents Beware: Infant Ibuprofen Recalled Over Dosage Problem

Ibuprofen is one of the most common over-the-counter medications given to young kids, but a huge new recall on the drug has parents on high alert.
Read more: Parents Beware: Infant Ibuprofen Recalled Over Dosage Problem

Product Recall Alerts: HEALTH ALERT: Retailers nationwide recalling infants' ibuprofen

HEALTH ALERT: Retailers nationwide recalling infants' ibuprofen .... That manufacturer, New Jersey-based Tris Pharma Inc., says the recall affects ... received no reports of infants injured as a result of taking the recalled ibuprofen.
Read more: HEALTH ALERT: Retailers nationwide recalling infants' ibuprofen

Product Recall Alerts: Recall Alert! Baby Ibuprofen From Walmart, CVS, and Family Dollar Has Been Recalled

A press release from Tris Pharma - a company based in New Jersey - just recalled three lots of Infants' Ibuprofen Concentrated Oral Suspension, USP ...
Read more: Recall Alert! Baby Ibuprofen From Walmart, CVS, and Family Dollar Has Been Recalled

Product Recall Alerts: Recall Alert: Pharma Company Pulls Infant Ibuprofen From CVS, Walmart, Family Dollar

Tris Pharma, Inc. has voluntarily recalled a popular infant's Ibuprofen product that is being sold at Walmart, CVS and Family Dollar. The recalled lots ...
Read more: Recall Alert: Pharma Company Pulls Infant Ibuprofen From CVS, Walmart, Family Dollar

Product Recall Alerts: RECALL ALERT: Infant ibuprofen products

NBC – A New Jersey pharmaceutical company has recalled three lots of infant ibuprofen product over concerns that there may be a higher ...
Read more: RECALL ALERT: Infant ibuprofen products

Product Recall Alerts: Recall alert: Infant ibuprofen sold at Walmart, CVS, Family Dollar

Tris Pharma, Inc., has recalled three lots of infant ibuprofen because of a formulation error creating a potency that could cause babies to develop ...
Read more: Recall alert: Infant ibuprofen sold at Walmart, CVS, Family Dollar

Product Recall Alerts: RECALL ALERT: Infant ibuprofen sold at CVS, Family Dollar and Walmart

Tris Pharma, Inc. is recalling three lots of infants' liquid Ibuprofen because they may contain higher concentrations of ibuprofen than advertised.
Read more: RECALL ALERT: Infant ibuprofen sold at CVS, Family Dollar and Walmart

Product Recall Alerts: Infant ibuprofen sold at CVS, Walmart, Family Dollar recalled

Tris Pharma Inc. issued the recall Wednesday, affecting lots sold at Walmart, CVS, and Family Dollar. The products were labeled to contain 50 mg of ...
Read more: Infant ibuprofen sold at CVS, Walmart, Family Dollar recalled

Product Recall Alerts: CONSUMER ALERT: Infant ibuprofen recalled sold at Walmart, CVS, Family Dollar

Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the ...
Read more: CONSUMER ALERT: Infant ibuprofen recalled sold at Walmart, CVS, Family Dollar

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics

FDA releases new strategic framework to advance use of real-world evidence to support development of drugs and biologics
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of vitro companion diagnostics for classes of oncology therapeutic products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

Pharma Reviews: Forthcoming challenges and changing skill sets for Indian pharmaceutical industry in next decade

What was noticeable was major Indian pharma companies initiating their defined and conscious journey in this direction. In fact the status of this ...
Read more: Forthcoming challenges and changing skill sets for Indian pharmaceutical industry in next decade

Product Recall Alerts: Infants' ibuprofen sold at Walmart, CVS, Family Dollar recalled

The product is used as a pain reliever/fever reducer and was packaged in 0.5 oz. bottles for the recalled lots listed here. Tris Pharma, Inc. sold the ...
Read more: Infants' ibuprofen sold at Walmart, CVS, Family Dollar recalled

Product Recall Alerts: Voluntary nationwide recall issued for infant ibuprofen sold at Walmart, CVS, Family Dollar

(WFLA) – A voluntary nationwide recall has been issued for three lots of infant ibuprofen. The recalled lots of the product have been found to ...
Read more: Voluntary nationwide recall issued for infant ibuprofen sold at Walmart, CVS, Family Dollar

Product Recall Alerts: Infant liquid ibuprofen sold at Walmart, CVS and Family Dollar recalled

Recall Alert. Infant liquid ibuprofen sold at Walmart, CVS and Family Dollar recalled ... Several brands of infant liquid ibuprofen are being recalled as they might contain higher and ... (NSAID) 50 mg per 1.25 mL" product sold and packaged in 0.5 oz. bottles at CVS Pharmacy, Family Dollar and Walmart.
Read more: Infant liquid ibuprofen sold at Walmart, CVS and Family Dollar recalled

Pharma Reviews: Do we need powerful Law on Medical devices in India?

Though India's medical devices market has become the hub of global majors like Medtronic, Stryker, Abbott, Bayer and Johnson & Johnson, ...
Read more: Do we need powerful Law on Medical devices in India?

Pharma Reviews: India registers 10% growth in containerised trade in Q3 2018, says report

The demand for India-made goods such as vehicles and mechanical ... The report said the Indian pharma sector witnessed high export growth to ...
Read more: India registers 10% growth in containerised trade in Q3 2018, says report

Pharma Reviews: Sun Pharma shares fall 7.5% after whistleblower email to Sebi

According to the whistleblower, acquisitions by Sun Pharma Group of overseas pharmaceutical companies and many Indian brokerage firms were ...
Read more: Sun Pharma shares fall 7.5% after whistleblower email to Sebi

Pharma Reviews: Closing Bell: Sensex ends flat, Nifty fails to close above 10900; Sun Pharma down 8%

Pharmaceuticals were the big losers, with the Nifty Pharma ending over 2 ... Further India's GDP and fiscal deficit data disappointed the market. Hence ...
Read more: Closing Bell: Sensex ends flat, Nifty fails to close above 10900; Sun Pharma down 8%

Pharma Reviews: Market Live: Selling in all sectors drags Nifty below 10900; Sensex marginally lower; RIL, Sun ...

Global research firm believes that the Indian tyre industry is witnessing a .... Sun Pharma cracks Shares of Sun Pharmaceuticals are down around 9 ...
Read more: Market Live: Selling in all sectors drags Nifty below 10900; Sensex marginally lower; RIL, Sun ...

US FDA News: FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
Read more: FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care

Pharma Reviews: Top stocks to watch out for on December 3: Sun Pharma, Maruti Suzuki, Tata Motors, SBI

The Indian market is set for a positive start on Monday, taking cues from its Asian peers after the top economic leaders US and China brokered a truce ...
Read more: Top stocks to watch out for on December 3: Sun Pharma, Maruti Suzuki, Tata Motors, SBI

Pharma Reviews: #ImplantFiles: Law on medical devices has waited 12 years

Successive governments in India have neglected the medical devices sector. For over 12 years, a proposed legislation, the Medical Device ...
Read more: #ImplantFiles: Law on medical devices has waited 12 years

Pharma Reviews: #ImplantFiles: Pharma majors gave freebies to doctors, claimed tax benefits

Records accessed by The Indian Express show that several pharmaceutical and medical devices manufacturers have claimed tax benefits on crores ...
Read more: #ImplantFiles: Pharma majors gave freebies to doctors, claimed tax benefits